AVKARE Inc.: Drug Recall
Recall #D-1329-2022 · 07/20/2022
Class III: Low Risk
Recall Details
- Recall Number
- D-1329-2022
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- AVKARE Inc.
- Status
- Terminated
- Date Initiated
- 07/20/2022
- Location
- Pulaski, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8328 bottles
Reason for Recall
Labeling: Label Error on Declared Strength
Product Description
Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4
Distribution Pattern
Nationwide within the United States
Other Recalls by AVKARE Inc.
- Class III: Low Risk 06/09/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.